HMMR and non-small cell lung carcinoma: Taken together, expression of RHAMM is a valuable prognostic factor of lung adenocarcinoma, and our findings suggest that RHAMM, most likely RHAMMB, is a potential therapeutic target for preventing metastatic NSCLC.